GRAY Jan 2023 2.500 call
| Previous Close | 0.5500 |
| Open | 0.5500 |
| Bid | 0.3500 |
| Ask | 0.7000 |
| Strike | 2.50 |
| Expire Date | 2023-01-20 |
| Day's Range | 0.5500 - 0.5500 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 22 |
- Zacks
Graybug (GRAY) to Review Strategic Alternatives, Stock Up
Graybug's (GRAY) board of directors is set to review strategic options focused on maximizing shareholder value, including a potential sale of the company. Shares rise.
- Simply Wall St.
Will Graybug Vision (NASDAQ:GRAY) Spend Its Cash Wisely?
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
- GlobeNewswire
Graybug Announces Review of Strategic Alternatives
BALTIMORE, June 28, 2022 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of ocular diseases, today announced that its Board of Directors will conduct a comprehensive review of strategic alternatives focused on maximizing shareholder value. As part of this process, the Company will explore the potential for an acquisition, company sale, merger, divestiture of assets, private placem
